Wildfire Smoke Exposure During Pregnancy May Increase Autism Risk in Offspring

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 19, 2026.

via HealthDay

THURSDAY, Feb. 19, 2026 -- Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a study published in the February issue of Environment International.

Karl O’Sharkey, Ph.D., M.P.H., from the University of California, Los Angeles, and colleagues examined associations between wildfire-specific fine particulate matter <2.5 μm (PM2.5) exposures and ASD risk in California births. The analysis included data from 8.6 million births in California from 2001 to 2019, which were linked to California Department of Developmental Services records through 2022.

The researchers found that continuous wildfire-specific exposures during the pregnancy period were weakly associated with ASD. Stronger effects were seen at high exposure percentiles and during intense wildfire episodes (≥35 µg/m3). Among children in the lowest quartile of prenatal background PM2.5, associations were most pronounced, with odds of ASD increasing by 50 percent for those above the 90th percentile of wildfire PM2.5 during pregnancy. In metro areas, wildland-urban-interface (WUI)-related PM2.5 was associated with ASD, suggesting unique toxicity. In nonmetro regions, the effects were generally stronger, with the exception of WUI-related PM2.5. Additionally, the effects were stronger in White children and for births occurring after the implementation of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition. There were minimal sex differences, but stronger effect estimates for WUI-related PM2.5 and high exposure episodes were seen for males.

"Together, these results suggest that air pollution during pregnancy is not a single, uniform exposure, and that the source and composition of pollution, as well as timing and intensity of exposure, matter when it comes to neurodevelopment," O’Sharkey said in a statement.

Two authors disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-02-20 09:26

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords